Why the study?
Does CAAS A-Valve software accurately define the optimal angiographic projection compared to MSCT in patients undergoing TAVI?
Does CAAS A-Valve software accurately define the optimal angiographic projection compared to MSCT in patients undergoing TAVI?
The CAAS A-Valve software provides an acceptable alternative to MSCT for defining the optimal angiographic projection during TAVI.
Answers are grounded in this paper and cite their sources.
Software shows acceptable OAP agreement with MSCT in TAVI; leaves open prospective validation before clinical adoption.
Background: Proper selection of the C-arm angulation during transcatheter aortic valve implantation ( TAVI ) is essential. Currently m ulti slice computed tomography (MSCT) is increasingly used to determine the C-arm angulation and is considered the gold standard. Yet, MSCT is not available in the catheterization laboratory and requires expertise. We sought to evaluate the accuracy of a novel software providing the optimal angiographic projection ( i.e. three cusps on one line, equally in size and posterior, right and left cusp sequence- optimal angiographic projection [ OAP ] ) based on two contrast angiograms. Methods: Software was validated by comparing the difference in OAP between MSCT (reference) and software (CAAS A-Valve) in 67 patients and by q ualitative comparison of the aortograms performed in accordance to MSCT and CAAS A-Valve defined OAP in 20 patients by 2 blinded assessors. Results: The median (IQR) difference in the OAP between MSCT and software was 12.4 (7.5-20.1) and 18.9 (10.8-28.5) degrees. For the qualitative comparison, an overall score ≥ 2 (acceptable-perfect) of 90% was reached by both observers for OAP derived by MSCT. It was 85 % and 90% (observer 1 and 2) for OAP derived from the software and was 90% after consensus. The interobserver variability (mean difference and SD ) for assessment of OAP curve and OAP itself was 1.6 ( SD = 5.8, p = .23) and 9.5 ( SD = 18.4) degrees ( p = .03) respectively . Conclusions: The CAAS A-Valve software adequately defines the OAP and is clinically useful in patients who do not have a MSCT prior to TAVI.
No takes yet. Share an insight, caveat, or question.
Faquir et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: